Stereotactic Body Radiotherapy
Drug timelines are a Plus or Pro feature.
5 regulatory and trial events tracked for Stereotactic Body Radiotherapy, covering 2013-03-06 to 2022-05-03. Get the full timeline:
Most recent: Clinical Trial Update: Nivolumab Plus Stereotactic Body Radiotherapy in II and III Line of Patients With Metastatic Renal Cell Carcinoma [Phase 2]